Drugs / pCMVS2.S
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00536627 | Jan 2008 → Nov 2010 | chronic hepatitis B virus infection | French National Agency for Research on AIDS and Viral Hepatitis | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pCMVS2.S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00536627 ↗ |
| Action | Restore | “The purpose of this study is to determine if DNA vaccination of chronic HBV patients under treatment with NRTI can restore T-cell responsiveness” NCT00536627 ↗ |
| Modality | Vaccine | “using a HBV envelope-expressing DNA vaccine” PMID 24555998 ↗ Feb 2014 |
| Route | Intramuscular | “one received five intramuscular injections of vaccine” PMID 24555998 ↗ Feb 2014 |